GLP - 1
Clinical trials for GLP - 1 explained in plain language.
Never miss a new study
Get alerted when new GLP - 1 trials appear
Sign up with your email to follow new studies for GLP - 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an app boost the power of Weight-Loss drugs?
Disease control Not yet recruitingThis study aims to see if a 4-month digital lifestyle coaching program helps adults who are taking GLP-1 medications (like Ozempic or Wegovy) improve their health habits and outcomes. Researchers will enroll 220 adults and randomly assign them to either start the coaching program…
Matched conditions: GLP - 1
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could a popular weight loss drug help beat rectal cancer?
Disease control Not yet recruitingThis study is testing if adding a weight loss medication (a GLP-1 receptor agonist like semaglutide) to standard pre-surgery cancer treatment improves results for overweight patients with locally advanced rectal cancer. Researchers will compare two groups: one gets the standard t…
Matched conditions: GLP - 1
Phase: PHASE2 • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Can a gut health pill stop weight regain after popular drugs?
Disease control Not yet recruitingThis study is testing whether a daily probiotic supplement can help people keep weight off after they stop taking GLP-1 medications like Ozempic or Wegovy. It will involve 128 adults who recently stopped their GLP-1 treatment. Participants will take the supplement or a placebo fo…
Matched conditions: GLP - 1
Phase: NA • Sponsor: Metagenics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC